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Objective: To clarify the merits of various surgical approaches, we studied the
outcome after composite valve graft versus separate valve and graft replacement
versus conservative valve treatment with replacement of the ascending aorta in
patients with acute type A aortic dissection complicated by aortic regurgitation.
Methods: Between 1967 and 1999, 123 patients (mean age 56  15 years) under-
went composite valve graft replacement (n  21), separate valve and graft replace-
ment (n  20), or conservative valve treatment (n  82 [commissural resuspension
in 46]); follow-up averaged 6.5 years (95% complete).
Results: The 30-day, 1-year, and 6-year survival estimates of 85%  4%, 79%  5%,
and 69%  5% (1 standard error of mean), respectively, after conservative valve
treatment were similar to 86% 8%, 81% 9%, and 65% 16%, respectively, with
composite valve graft replacement and better (but insignificantly so) than 70% 10%,
70% 10%, and 45% 11%, respectively, with separate valve and graft replacement.
The 6-year freedom from proximal reoperation was 95% 3%, 89% 10%, and 100%
in conservative valve graft, separate valve and graft, and composite valve graft sub-
groups, respectively (P  not significant). Cox regression multivariable analysis iden-
tified that previous sternotomy (hazard ratio [or e] 95% confidence interval 1.4-10.9, P
 .006), hypertension (0.99-2.9, P  .05), cardiac tamponade (1.1-4.0, P  .03), and
stroke (1.7-7.0, P .001) increased the hazard of death. No factors predicting a higher
likelihood of late proximal reoperation were identified.
Conclusions: In patients with acute type A aortic dissection and aortic regurgitation,
there was no significant difference in overall survival or reoperation rates among
these surgical approaches. We try to save the valve whenever possible unless the
aortic root is pathologically dilated (eg, Marfan syndrome or annuloaortic ectasia)
or destroyed by the dissection process, when composite valve graft or valve-sparing
aortic root replacement is indicated.
In treating patients with acute dissection of the aortic root complicated byaortic regurgitation (AR), the choice between composite valve graft (CVG)or valve-sparing aortic root replacement and conservative procedures (re-pair of the aortic root with conservation of the aortic valve and sinuses)(CONS) is largely dictated by operative findings, patient characteristics,and surgeon preference. A prospective, randomized, controlled trial to
elucidate the relative merits of radical versus conservative surgical treatment of the
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dissected aortic root is logistically impractical; instead, ret-
rospective studies may serve to elucidate the best patient
and pathoanatomic substrate amenable to a conservative
versus a more aggressive approach to the aortic root and
thus refine our surgical decision-making process. We there-
fore analyzed the outcome of CVG replacement of the aortic
root versus subtotal aortic replacement with separate aortic
valve and graft (SVG) versus CONS valve treatment with
graft replacement of only the tubular segment of the ascend-




The cardiovascular surgery database at Stanford University School
of Medicine contained 307 consecutive patients who underwent
surgery for spontaneous acute type A aortic dissection from Jan-
uary 1967 to July 1999. Of these, 123 patients had more than
trivial AR and underwent aortic root reconstruction or replace-
ment. Three treatment groups were defined: Twenty-one patients
(17%) were repaired using a CVG from 1989 to 1999, 20 patients
(16%) were repaired using an SVG from 1972 to 1992, and 82
patients (67%) were repaired by replacement of the ascending
aorta and aortic valve conservation from 1967 to 1999 (CONS)
(Figure 1). Within the CONS group, simple commissural resus-
pension was performed in 46 patients. The diagnosis was made by
aortography, computed tomography, magnetic resonance imaging,
transthoracic or transesophageal echocardiography, or surgical
findings. Patient clinical characteristics are detailed in Appendix 1.
Surgeons were categorized by experience as “high volume,” those
who performed 30 or more surgical repairs for aortic dissection (5
of 16 surgeons), and “low volume,” those who performed 30 or
less repairs (11 surgeons) (Appendix 1). The heterogeneous treat-
ment groups reflected inherent patient selection and surgeon bi-
ases.
Definitions
The dissection was classified according to the 1970 Stanford
system.1 The average time lapse from symptom onset to operation
was 48  62 hours. There was no difference in disease acuity
among the treatment groups. Patients with type A intramural
hematoma were also included (Appendix 1). AR was diagnosed by
preoperative echocardiography or aortography.
Operative Methods
Although variability in surgical techniques was present among the
individual surgeons and the surgical techniques evolved over the
years, the surgical approach uniformly was to resect all of the
tubular portion of the ascending aorta and, if identified, the pri-
mary intimal tear. Earlier, cannulation of the femoral artery was
used for cardiopulmonary bypass, but the right axillary artery
became the preferred site for arterial cannulation in the late 1990s.2
In recent years, most surgeons have striven to avoid aortic cross-
clamping whenever possible, resecting the underside of the trans-
verse aortic arch and performing an open distal “hemiarch” anas-
tomosis using profound hypothermic (20°C -25°C bladder
temperature) circulatory arrest. In the early 1990s, a brief period of
retrograde cold blood cerebral perfusion during completion of the
open distal anastomosis was used by some surgeons. When the
circulatory arrest period is anticipated to be longer than 30 min-
utes, selective antegrade cerebral perfusion is now used by most
surgeons. During antegrade reperfusion and rewarming, attention
is then directed to the proximal aortic root.
The most commonly performed proximal aortic procedure was
reconstructing the sinotubular junction circumferentially and tube
graft replacement of the ascending aorta. The native aortic valve
was preserved whenever feasible. The main technical features of
valve resuspension included complete transection of the proximal
aorta, obliteration of the proximal false lumen down to the level of
the aortic annulus with a custom-tailored piece of Teflon (DuPont,
Wilmington, Del) felt inside the false lumen, and resuspension of
the aortic valve commissures with circumferential suture recon-
struction of the aorta.3 Frequently, this proximal cuff was rein-
forced by an external layer of Teflon felt. We have never relied
solely on placing individual pledgeted mattress sutures at the tops
of the commissures for this purpose. In the last 2 years, BioGlue
(Cryolife, Inc, North West Kennesaw, Ga) has been used instead of
Teflon felt. The graft size was based on the goal of restoring the
sinotubular junction diameter to approximate the aortic annular
Figure 1. Patient distribution by year according to aortic root treatment method.
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diameter. If attempts at commissural resuspension did not result in
valvular competency, then aortic valve replacement using either
the SVG or CVG approach was performed.
If the sinuses of Valsalva were excessively dilated (because of
annuloaortic ectasia; n 15, 71% 10% of the CVG group [70%
confidence interval]), pathologically diseased (eg, the Marfan syn-
drome [MFS]), or destroyed by the acute dissecting process (n 
3, 15%  8% of CVG) with or without irreparable compromise of
the coronary arteries (n  3, 15%  8% of CVG), complete aortic
root replacement was performed. If it was judged that valvular
competency could not be satisfactorily restored or if severe valve
pathology was present, valve replacement was performed. CVG
replacement (mechanical valve 20; bioprosthetic valve 1) and
reimplantation of the coronary ostia was always performed as an
open procedure using Carrel coronary button anastomoses avoid-
ing “wrap inclusion” (Bentall procedure).
In SVG procedures, the bulk of the sinuses of Valsalva were
resected leaving small tongues of aortic root tissue surrounding the
coronary ostia. After the aortic valve was excised, a mechanical (n
 1) or bioprosthetic (n  19) valve was inserted, and a woven
synthetic graft was then anastomosed to the proximal and distal
aortic cuffs (which were reinforced by 1 or more layers of Teflon
felt). The extent of distal aortic resection in patients who under-
went operation using hypothermic circulatory arrest and distribu-
tion of the location of the primary intimal tear are summarized in
Appendix 1.
Follow-up
Current follow-up was obtained by telephone or written commu-
nication or both. Follow-up was 95% complete (n  117), ex-
tended to a maximum of 30.7 years, and totaled 761 patient-years
(Appendix 1).
Postoperative Care
Negative inotropic drug treatment was advised indefinitely, even in
normotensive patients.4,5 Serial aortic surveillance with annual
computed tomography or magnetic resonance imaging scans was
also recommended, but compliance with this recommendation
could not be ensured.
Statistical Methods
Outcomes. Valve-related complications have been detailed in
a previous report.6 Time-related events studied included death at
any time after operation and reoperation for proximal aortic com-
plications. Freedom from these time-related events was estimated
by the nonparametric actuarial Kaplan-Meier method. For freedom
from reoperation, a nonfatal event, actual (or observed cumulative
frequency) probabilities were also computed. Analyses stratified
according to treatment modality were compared using the log-rank
test. Early mortality was defined as death within 30 days of
treatment or during the same hospitalization, regardless of time.
The variability of continuous data is expressed as mean  1 SD,
the variability of important fractions or ratios is expressed as
70% confidence levels (CL), and the variability of actuarial or
actual estimates is expressed as 1 SEM, approximately equiva-
lent to 70% CL. Events arising from 1 or more valve-related
complications were infrequent and thus were expressed as linear-
ized rates (events per patient-year).
Identification of predictors of outcome. The influence of 25
preoperative characteristics or dissection-related complications
(independent variables) on outcome (dependent variables) was
analyzed by using SPSS for Windows (Release 10.0.0; SPSS Inc,
Chicago, Ill). These independent variables included age, gender,
duration of symptoms, year of operation, surgeon experience,
shock, acute aortic insufficiency, paraplegia, visceral ischemia,
renal dysfunction, peripheral pulse deficit, arch involvement,
stroke, coronary artery disease, congestive heart failure, pulmo-
nary disease, liver disease, diabetes mellitus, prior stroke, MFS,
hypertension, previous dissection, previous sternotomy, tampon-
ade, and rupture (Appendix 1). The predictors of time-related
outcome were identified, and their hazard ratios (HR or e) with
95% CL were determined from Cox proportional hazards analysis.
Results
Survival
For all patients, the 30-day, 1-year, and 6-year actuarial
survival estimates were 85% 4%, 78% 5%, and 65%
5% (1 SEM), respectively. There was no significant dif-
ference in overall survival between the 3 treatment groups:
The 30-day, 1-year, and 6-year actuarial survival estimates,
respectively, were 86% 8%, 81% 9%, and 65% 16%
in the CVG group, 70%  10%, 70%  10%, and 45% 
11% in the SVG group, and 85%  4%, 79%  5%, and
69%  5% (1 SE) in the CONS group (Figure 2). The
apparent lower survival estimates in the SVG group were
not statistically significant. Risk factors for death at anytime
included previous sternotomy (n 5; multivariable HR 4.0,
95% CL 1.5-10.9, P  .006; univariable HR 5.2, 95% CL
2.0-13.6, P  .001), stroke (n  12; multivariable HR 3.3,
95% CL 1.6-7.0, P  .001; univariable HR 2.8, 95% CL
1.4-5.7, P  .005), cardiac tamponade (n  28; multivari-
able HR 2.1, 95% CL 1.1-4.0, P  .03; univariable HR 2.2,
95% CL 1.2-4.3, P  .01), and hypertension (n  65,
Figure 2. Actuarial survival estimates for all patients subdivided
according to treatment group.
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multivariable HR 1.7, 95% CL 0.99-2.9, P  .052; univa-
riable HR 1.9, 95% CL 1.1-3.1, P  .02). Neither treatment
method nor “high-volume surgeons” were associated with
any difference in survival.
Early Death
The hazard of death was highest immediately after opera-
tion (Figure 2). There was no difference in early death rate
among the treatment groups (Appendix 1). A Cox propor-
tional hazards regression model showed that shock (HR 5.8;
95% CL 1.5-23.4; P  .01) and stroke (HR 5.0; 95% CL
1.2-20.0; P  .02) predicted a higher likelihood of early
death.
Late Death
Death from aortic-related complications was defined as that
caused by progression of dissection and/or rupture and those
that were sudden and unexplained. The causes of late death
are listed in Table 1. None of the patients in the CVG group
died from an aortic-related complication; 2% of the patients
in the SVG group and 15% of the patients in the CONS
group could have possibly died as the result of an aortic
complication. This raw fractional difference in cause of late
deaths did not attain statistical significance. Stroke ac-
counted for 5% of late deaths in the CONS group and 2% in
the SVG group. Anticoagulant-related hemorrhage did not
cause any late deaths in the CVG group but was responsible
for 2% of late deaths in the SVG group. Comorbidities, such
as congestive heart failure, accounted for a high proportion
of late deaths in the CONS group relative to the CVG and
SVG groups, but more patients with residual aortic valve
regurgitation were not detected at follow-up in the CONS
group. Sepsis led to 1 late death in the CVG group in the
absence of evidence of endocarditis at autopsy.
Proximal Aortic and Aortic Valve Reoperation
The 6-year actuarial freedom from proximal aortic or aortic
valve reoperation was 95%  3%, 89%  10%, and 100%
in the CONS, SVG, and CVG subgroups, respectively (P 
not significant [NS]). Specifically, the 6-year actuarial free-
dom estimates from proximal aortic reoperation were 99%
 1%, 89%  10%, and 100%  2% in the CONS, SVG,
and CVG subgroups, respectively (P  NS); the 6-year
actuarial freedom estimates from aortic valve reoperation
were 94%  4%, 88%  12%, and 100%  2%, respec-
tively (P  NS). The 6-year actual freedom from proximal
aortic or aortic valve reoperation was 98%  1%, 95% 
1%, and 100%  2% in the CONS, SVG, and CVG groups,
respectively, and did not differ significantly among any of
the treatment groups (Figure 3). No risk factors predictive of
proximal aortic or aortic valve reoperation could be identi-
fied, including MFS. Treatment method was not associated
with any difference in the probability of proximal aortic or
aortic valve reoperation.
Major Morbidity and Valve-Related Complications
There was no significant difference in the rate of early
postoperative bleeding or neurologic complications among
treatment methods (Appendix 1). The number of valve-
related events was few, particularly in the CVG group; there
also was no statistical difference in the linearized rate of
valve-related complications (Table 2).
Discussion
In most patients presenting with acute type A aortic dissec-
tion complicated by AR, the aortic valve can be conserved
by commissural resuspension and supracoronary aortic
grafting. In most series, the number of repaired valves
expressed as a percentage of total number of regurgitant
TABLE 1. Causes of late deaths subdivided according to
proximal aortic root surgical treatment method
CVG SVG CONS
N (%) N (%) N (%)
Dissection rupture/extension 1 (2) 10 (12)
Sudden, unexplained 1 (2)
Arrhythmia 2 (4)
Myocardial infarction 1 (2)
Congestive heart failure 1 (2) 7 (9)
Sepsis 1 (2)
Renal failure 1 (2) 3 (4)
Respiratory failure/pneumonia 1 (2) 5 (6)
Stroke 1 (2) 4 (5)




CVG, Composite valve graft; SVG, separate replacement of the aortic valve
and ascending aorta; CONS, aortic valve conservation.
Figure 3. Actual freedom from proximal aortic reoperation esti-
mates in all patients subdivided according to how the proximal
aortic reconstruction was surgically performed.
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valves ranged from 51%6-9 to 100%.10 At Stanford, the
aortic valve has been conserved in acute dissection with
increasing frequency during the last decade (Figure 1): The
fraction of leaking aortic valves repaired increased from
52%  6% in a 1991 2-center report6 (Duke University) to
67%  4% in this present study. Despite our increased zeal
for preservation of the aortic valve, the actuarial estimate of
freedom from aortic valve reoperation is still high (94% 
4% at 6 years) compared with the earlier Stanford-Duke
estimate of 100% at 5 years.6 These results indicate that the
surgeons over the years consistently adhered to fairly uni-
form anatomic and pathologic guidelines in terms of what
procedure to perform. Patients with MFS, annuloectasia, and
extensive aortic root dissection only rarely had the valve con-
served, as other groups advocate.6,9-15 For example, Casselman
and colleagues13 reported that an aortic valve annulus greater
than 27 mm in diameter was associated with a 4.2-fold increase
in relative risk of aortic root reoperation.
Contrary to our experience, the use of Teflon felt for
reconstruction of the aortic root has not met with wide-
spread uniform success.9,13,16 Niederhauser and colleagues9
reported that at 2 years, patients who underwent gelatin-
resorcin-formaldehyde (GRF) (or “French” glue) recon-
struction of the aortic root had an increased freedom from
reoperation on the aortic root (92% vs 70%, P  .02) and
event-free survival (77% vs 41%, P  .02) compared with
simple suture resuspension. Although we recognize the ben-
efits of a tissue adhesive in creating a sturdy substrate for
suturing and have moved to BioGlue as a substitute for
Teflon felt, we remain dubious about GRF in light of recent
reports of GRF-related tissue necrosis of the aortic root.17
Overall, supra-commissural aortic valve resuspension
has exhibited relatively excellent long-term durability in
this and other series.6-8,10,11,16,18 There is, however, 1 con-
founding factor: The reported long-term durability of the
repair may artifactually be better when all patients are
considered instead of just those with AR.8,11,18,19 Pessotto
and coworkers7 and Mazzucotelli and coworkers11 reported
that the presence of moderate-to-severe aortic insufficiency
in patients portends an increased rate of reoperation
(37%-39% of patients) compared with patients with no or
mild AR. Kirsch and colleagues from the Hoˆpital Henri
Mondor20 reported that severe AR increased the HR of
reoperation on the proximal aorta by 3.6-fold (1.44-9.07;
95% confidence interval) and recommended more frequent
consideration of CVG (or valve-sparing aortic root replace-
ment) at the time of the initial operation in patients with
severe AR. We concur given that moderate-to-severe AR
may be a surrogate for more pronounced aortic root disease.
Freedom from aortic root reoperation was independent of
both surgical treatment method and patient-related risk fac-
tors. The MFS did not emerge as a risk factor for reopera-
tion, as intuition would dictate, perhaps because most pa-
tients with MFS received a CVG procedure. The fact that
this analysis was unable to identify factors predicting an in-
creased likelihood of reoperation reflects appropriate patient
selection for the various procedures, namely, customizing the
operative procedure to the patient and his or her disease.
The actuarial estimate of freedom from reoperation in the
SVG group was “artificially” lowered by the strong com-
peting hazard of death; when expressed as an actual esti-
mate, freedom from reoperation was comparable to that in
the CONS and CVG groups (Figure 3). Nonetheless, we
basically abandoned the SVG procedure in 1989 (Figure 1).
Indeed, Moon and colleagues19 reported a very high oper-
ative mortality rate of 50%  16% for patients undergoing
SVG; however, similar to our findings, they found no dif-
ference in late aortic reoperation or survival depending on
which aortic root operative technique was performed ini-
tially. Patient survival, including early postoperative mor-
tality, also was not influenced by treatment method; it seems
that patient substrate was the main determinant of survival,
a finding corroborated by Niederhauser and colleagues.9
The predictors of short- and long-term survival were pa-
tient-related and dissection-related factors, which for the
most part cannot readily be modified. There is some debate
concerning whether long-term survival and operative mor-
tality risk after either an aggressive or a more conservative
TABLE 2. Linearized rates (%/patient-year) of valve-related complications tabulated according to type of proximal surgical
procedure performed
CVG SVG CONS
N Rate N Rate N Rate
Residual valve disease 0 0 3 2 3.1 7 1.2 1.2
Stroke 0 0 2 1.3 2.5 3 0.5 0.8
Peripheral thromboembolism 0 0 1 0.7 1.9 0 0
Hemolysis 0 0 0 0 0 0
Anticoagulant-related
Hemorrhage 1 1.3 2.5 0 0 0 0
Endocarditis 0 0 0 0 1 0.2 0.5
Rate is events/100 patient-years, which is equivalent to %/patient-year (70% confidence limits).
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aortic root procedure are comparable in centers with special
thoracic aortic expertise.8,9,11,18,19 Ergin and coworkers21
from Mount Sinai reported that patients undergoing total
root replacement represented a higher operative risk subset
as the result of having substantial AR and coronary dissec-
tion, but paradoxically had substantially better event-free
survival estimates at 5 years (88%  12% vs 67%  9%)
and 9 years (88%  22% vs 63%  19%); these authors
recommended that root replacement should be considered
more frequently. On the other hand, data reported by Sabik
and colleagues18 from the Cleveland Clinic showed that
CVG carried a significant adverse impact on overall sur-
vival (P  .0009), primarily in the early hazard phase. von
Segesser and coworkers8 have argued that simple preserva-
tion of the valve offers a sound long-term prognosis without
exposing the patient to undue risk. The general consensus
today6-8,13-15,18-20,22 indicates that a more aggressive surgi-
cal approach (eg, CVG) should be considered only in spe-
cial circumstances.
The David “reimplantation”23 or Yacoub “remodeling”24
methods of valve-sparing aortic root replacement combined
the benefits of aortic root replacement as well as preserva-
tion of the aortic valve; thus, this may be an even better
alternative for repair of the dissected aortic root in highly
selected patients with an acute type A aortic dissection and
AR. The early results reported by Graeter and colleagues
from Homburg,25 Leyh and colleagues26 from Lubeck, and
the cardiovascular surgical group from Hannover27 have
been encouraging. The outcome after CVG and CONS
procedures reported in this article will serve as clinical
benchmarks in the future to assess the putative long-term
benefits of this “ultraradical” valve-sparing surgical ap-
proach as applied to these very challenging patients.
Limitations
The current study was limited by the absence of universal
follow-up echocardiographic data; it is therefore highly likely
that the freedom from aortic valve reintervention rate was
underestimated by some patients having moderate or possibly
even severe AR yet not having undergone reoperation. We
were unable to demonstrate any long-term benefit or draw-
backs associated with repairing the native aortic valve com-
pared with replacement with either a mechanical or a biologic
valve substitute in terms of structural and nonstructural valve
failure, anticoagulant-related hemorrhage, endocarditis, or
thromboembolic events, but because late attrition was high and
serial echocardiographic surveillance was incomplete, this may
be attributable to inadequate statistical power.
Acute AR was present in only 123 of 307 patients (40%),
which is less than the 59% and 100% reported by Ehrlich
and coworkers28 and Niederhauser and coworkers, respec-
tively.9 This discrepancy is probably attributable to different
methods for classifying the severity of acute AR rather than
the acuity of disease. A possible selection bias may have
been introduced by excluding 28 patients in the CVG and
SVG groups who did not have AR preoperatively; analysis
of all 307 patients with or without AR did not change the
major conclusions, but SVG was associated with a higher
probability of proximal aortic reoperation.
Conclusion
There was no significant difference in overall survival or
proximal reoperation rates after either an aggressive or a
conservative operation for patients with acute type A aortic
dissection. We concur with the editorial philosophies es-
poused recently by Elefteriades14 and Kron22 that the best
operation is one that is customized to each individual pa-
tient. We presently prefer CONS, CVG, or David reimplan-
tation valve-sparing aortic root replacement depending on
the individual patient and specific pathoanatomic features
encountered.
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APPENDIX 1. Characteristics of 123 patients with acute type A aortic dissection complicated by aortic regurgitation,










N (%) N (%) N (%) N (%)
Demographics
Age (mean  SD) (yr) 56 15 51 19* 51 15* 59 13*
Gender
Male 84 (68) 15 (71) 15 (75) 54 (66)
Female 39 (32) 6 (29) 5 (25) 28 (34)
Surgeon experience 100 (81) 20 (95)** 10 (50)** 70 (85)**
Presentation
Duration of symptoms (hrs) 48 62 40 39 45 47 51 70
Year of operation 1987 9 1996 3** 1982 5** 1986 10**
Year of operation (range) 1967-1999 1989-1999 1973-1992 1967-1999
Shock 12 (10) 2 (10) 2 (10) 8 (10)
Paraplegia 3 (2) 0 (0) 0 (0) 3 (4)
Visceral ischemia 0 (0) 0 (0) 0 (0) 0 (0)
Renal dysfunction 25 (20) 0 (0)* 6 (30)* 19 (23)*
Peripheral pulse deficit 58 (47) 5 (24) 11 (55) 42 (51)
Extent of dissection
Ascending aorta 14 (11) 2 (10) 2 (10) 10 (12)
Asc Ao  Arch 18 (15) 4 (19) 4 (20) 10 (12)
Asc Ao  Arch  Dsc Thor Ao 28 (23) 4 (19) 2 (10) 22 (27)
Asc Ao  Arch  Dsc Thor Ao  Abd Ao 63 (51) 11 (52) 12 (60) 40 (49)
Intramural hematoma 1 (1) 0 (0) 0 (0) 1 (1)
Stroke 12 (10) 1 (5) 1 (5) 10 (12)
Associated conditions
CAD 31 (25) 6 (29) 3 (15) 22 (27)
CHF 10 (8) 1 (5) 1 (5) 8 (10)
Pulmonary disease 27 (9) 12 (6) 15 (12) 15 (12)
Liver disease 5 (4) 0 (0) 1 (5) 4 (5)
Diabetes mellitus 7 (6) 2 (10) 1 (5) 4 (5)
Prior stroke 7 (6) 0 (0) 0 (0) 7 (9)
Marfan syndrome 14 (11) 8 (38)** 3 (15)** 3 (4)**
Hypertension 65 (53) 8 (38)* 7 (35)* 50 (61)*
Previous aortic dissection 2 (2) 2 (10)** 0 (0)** 0 (0)**
Previous sternotomy 5 (4) 1 (5) 0 (0) 4 (5)
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Dr H. Storm Floten (Portland, Ore). For their continued fine
work in the management of acute type A dissection, I commend Dr
Lai, Dr Miller, and their associates at Stanford University. Acute
type A dissection is a condition that still tightens the sphincters of
the best of heart surgeons and still bears an early operative mor-
tality rate in the neighborhood of 25%. In their article they give a
flawless statistical analysis comparing 3 standard methods of deal-
ing with acute dissection of the root and aortic insufficiency. They
show that there is no statistical difference in the early or late
survival or in the reoperation rate for the 3 methods. Factors
affecting morality were reoperation, hypertension, tamponade, and
stroke. The highest risk of death was immediately after surgery,
and early death was predicted by shock and prior stroke. At the
Starr-Wood cardiac group and the Oregon Health Sciences Uni-
versity in Portland, we have adopted much of the same philoso-
phies as Stanford in the management of this condition. Most cases
involve valve repair or composite graft repair when we encounter
MFS, annular ectasia, or dilated root. We have not used separate
valve replacement and sleeve graft in saving the sinuses. Our
philosophy has been that if we cannot save the valve, why save the
sinuses that are the primary problem? This leaves the operative
decision largely between the 2 techniques of composite graft or
valve repair. Frankly, we find that in a normal-sized aorta the
commissural resuspension and sinus repair is an easier procedure,
and we are comforted by the report indicating that we may be
doing the right thing. The conduit procedure is easier when en-
countering MFS, a dilated aorta, or annular ectasia. The most
difficult cases are when there is a normal-sized root or small root
that has massive dissection, maybe all 3 sinuses, and, in particular,
when I see staining of blood south of the annulus down into the
endocardium and myocardium. These cases are going to really
require a conduit graft in my experience to avoid valve incompe-
tence and sinus rupture. We have not been able to consistently
duplicate the valve-preserving root-replacement procedures of
David and Yakoub, and I am reluctant to embrace their operations
for acute pathology that we are discussing today. Your techniques
at Stanford are hallmark to the success in management of acute
dissection. Complete resection of the aorta above the sinotubular
junction facilitated by profound hypothermia, no crossclamp, open
anastomosis at the arch and beyond, retrograde cerebral perfusion,
and selective antegrade perfusion are all critical techniques to be
used. We still repair the root with Teflon felt in the false lumen of
the sinuses and resuspend the aortic commissures. In addition, we
turn the adventitia in over the top of the felt to thereby circumfer-










N (%) N (%) N (%) N (%)
Operative findings
Tamponade 28 (23) 7 (33) 2 (10) 19 (23)
Aortic rupture 57 (46) 10 (48) 8 (40) 39 (48)
Site of PIT
Asc Ao 107 (87) 19 (91) 18 (90) 70 (85)
Arch 8 (7) 0 (0) 2 (10) 6 (7)
Dsc Thor Ao 3 (2) 1 (5) 0 (0) 2 (2)
Unknown 5 (4) 1 (5) 0 (0) 4 (5)
Arch resection 24 (20) 10 (48)** 0 (0)** 14 (17)**
Resection of PIT 111 (90) 18 (86) 18 (90) 75 (92)
Aortic crossclamp time (min) 90 42 143 38** 106 45** 72 26**
Cardiopulmonary bypass time (min) 147 63 216 64** 157 66** 127 48**
Coronary artery bypass graft 11 (16) 0 (0) 5 (25) 6 (12)
Postoperative complications
Bleeding 13 (11) 3 (15) 3 (18) 7 (9)
Stroke 13 (11) 1 (5) 3 (16) 9 (12)
Follow-up
Follow-up period 6.5 6.1 3.7 3.0 7.6 7.6 7.0 6.2
Early death 20 (16 3.3) 3 (14 7.8) 6 (30 11) 11 (13 3.8)
CVG, Composite valve graft; SVG, separate replacement of the aortic valve and ascending aorta; CONS, aortic valve conservation; visceral ischemia,
compromised arterial perfusion of anyintra-abdominal organ diagnosed by angiography or computed tomography or magnetic resonance imaging; renal
dysfunction, compromised renal perfusion by angiography, acute anuria, renal infarction, or serum creatinine  3 or blood urea nitrogen  40; peripheral
pulse deficit, loss of blood flow to extremities as documented by physical examination, angiography, or computed tomography, Asc Ao, ascending aorta;
Dsc Thor Ao, descending thoracic aorta; Abd Ao, abdominal aorta; CAD, coronary artery disease as indicated by a previous diagnosis of coronary disease
or myocardial ischemia or infarction; CHF, congestive heart failure; pulmonary disease, diagnosis of chronic obstructive pulmonary disease or significant
lung ailment; liver disease, total bilirubin 2.0 at the time of diagnosis; prior stroke, history of strokes or transient ischemic attacks; aortic rupture, presence
of blood in the pericardial cavity; site of PIT, site of primary intimal tear diagnosed either on preoperative imaging or at operation; surgeon experience,
“high-volume” surgeons who performed 30 or more surgical repairs for aortic dissection (comprising 5 of 16 surgeons in the database) versus 11
“low-volume” surgeons who performed 30 or less repairs; bleeding, postoperative hemorrhage requiring reoperation. *P  .05; **P  .01 by either 2 test
or analysis of variance.
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